Yorktown Management & Research CO Inc Pfizer Inc Transaction History

Yorktown Management & Research CO Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 06, 2020	SELL	$31.75 - $37.25 $271,462 - $318,487	-8,550 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$30.12 - $36.54 $257,526 - $312,417	8,550 New	8,550 $280,000
Q2 2019 Aug 02, 2019	SELL	$36.98 - $41.52 $1.85 Million - $2.08 Million	-50,000 Closed	0 $0
Q4 2018 Feb 08, 2019	SELL	$38.47 - $43.86 $226,973 - $258,774	-5,900 Reduced 10.55%	50,000 $2.18 Million
Q4 2017 Feb 13, 2018	BUY	$33.26 - $35.29 $648,570 - $688,155	19,500 Added 53.57%	55,900 $2.03 Million
Q2 2017 Aug 11, 2017	BUY	N/A	36,400	36,400 $1.22 Million

3,239

3.6B

77.1M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Yorktown Management & Research CO Inc, based on Form 13F filings with the SEC.

Stay updated on Yorktown Management & Research CO Inc with notifications on news.